Chapters

Transcript

Video

Association Between Anti-Sjogren Syndrome/Scleroderma Autoantigen 1 (SSCA1) Antibodies and Cancer in Systemic Sclerosis

Rheumatology fellow Rachel Wallwork discusses her latest research results on how an antibody in systemic sclerosis patients with cancer may be a key biomarker to predict possible cancer development.

Related Videos